Cardano Risk Management B.V. reduced its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 17.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 779,511 shares of the company's stock after selling 170,280 shares during the quarter. Cardano Risk Management B.V.'s holdings in Procter & Gamble were worth $114,307,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Carson Advisory Inc. grew its position in shares of Procter & Gamble by 0.5% in the fourth quarter. Carson Advisory Inc. now owns 12,124 shares of the company's stock valued at $1,738,000 after purchasing an additional 65 shares in the last quarter. Trilogy Capital Inc. lifted its holdings in Procter & Gamble by 1.1% during the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company's stock worth $901,000 after purchasing an additional 67 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in Procter & Gamble by 1.8% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company's stock worth $549,000 after purchasing an additional 67 shares during the period. Lorne Steinberg Wealth Management Inc. boosted its stake in Procter & Gamble by 2.7% in the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company's stock worth $376,000 after purchasing an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. grew its holdings in Procter & Gamble by 2.7% during the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company's stock valued at $376,000 after buying an additional 69 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: PG’s $3.8 billion acquisition of Thorne would expand its presence in vitamins, supplements and wellness products, providing a potential avenue for longer-term growth beyond its traditional consumer-staples categories. Procter & Gamble making $3.8 billion acquisition of supplements company Thorne
- Positive Sentiment: PureCycle Technologies reported that its first commercial recycled-resin deliveries to PG have begun, with select Downy detergent caps now in production. The development supports PG’s sustainability efforts and could help secure recycled materials for packaging. PureCycle Technologies Reports Second Quarter 2026 Results
- Neutral Sentiment: PG continues to be highlighted as a defensive consumer-staples and dividend stock amid market volatility. However, elevated Treasury yields may make dividend-paying equities somewhat less attractive relative to bonds. 5 Solid Dividend Stocks to Buy in August
- Negative Sentiment: Argus downgraded PG from “buy” to “hold.” The change removes a positive analyst catalyst and likely reflects concerns about valuation, modest recent sales growth and limited near-term upside.
- Negative Sentiment: Discussion surrounding the Thorne acquisition has focused on product quality and safety concerns. Although these are not confirmed problems, such concerns could increase reputational and integration risks for PG as it enters the supplements market. Procter & Gamble Buys Supplement Brand Thorne — People Have Thoughts
Procter & Gamble Stock Performance
NYSE:PG opened at $145.88 on Friday. The stock has a market cap of $339.09 billion, a P/E ratio of 22.04, a PEG ratio of 4.48 and a beta of 0.39. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The business's 50-day moving average price is $147.86 and its two-hundred day moving average price is $148.98. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. The company had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.Procter & Gamble's revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Friday, July 24th. Procter & Gamble's payout ratio is currently 65.71%.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $163.00 price target on shares of Procter & Gamble in a report on Monday, April 27th. Piper Sandler boosted their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Friday, April 24th. UBS Group upped their target price on shares of Procter & Gamble from $166.00 to $172.00 and gave the stock a "buy" rating in a report on Monday, April 27th. Barclays increased their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Finally, Sanford C. Bernstein began coverage on shares of Procter & Gamble in a research report on Thursday, June 11th. They set a "market perform" rating and a $156.00 price target for the company. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus price target of $161.52.
Read Our Latest Report on PG
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.